A US Hospital-Perspective Decision-Analytic Model of Once-Weekly Rezafungin Versus Daily Echinocandin Therapy in Hospitalized Adults With Candidemia or Invasive Candidiasis: Potential Cost Savings From Earlier Discharge. [PDF]
Lodise TP, Patel N.
europepmc +1 more source
Mitochondrial characteristics of echinocandin tolerance and resistance in <i>Candida glabrata</i> and <i>Candida krusei</i>. [PDF]
Xue P +9 more
europepmc +1 more source
929Comparison of Echinocandin vs Amphotericin B Based Therapy for Candida Infective Endocarditis: An Observational Cohort ...
Jacob Strahilevitz (520952) +11 more
core
In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of <i>Candida</i> (<i>Candidozyma</i>) <i>auris</i>. [PDF]
Balázsi D +8 more
europepmc +1 more source
Natural Product-Inspired Antifungal Drugs Introduced for Human Use from 1872 to August 2026. [PDF]
Butler MS, Capon RJ.
europepmc +1 more source
Multidrug Resistance and Host Adaptation in Candida Auris: From Molecular Mechanisms to Emerging Therapeutic Frontiers. [PDF]
Shao F, Wu T, Su J.
europepmc +1 more source
Species Distribution and Antifungal Susceptibility of Candida Isolates From Candidemia: Findings at a Tertiary Academic Medical Center From 2018 to 2025. [PDF]
Kilic A, Palavecino EL.
europepmc +1 more source
<i>In vitro</i> exposure to the agricultural triazole tebuconazole selects for fluconazole cross-resistance and echinocandin tolerance in <i>Candidozyma auris</i>. [PDF]
Peng L, Xu Y, Chen X, Li W, Guo L.
europepmc +1 more source
<i>Candida auris</i>: a review of global epidemiology, multidrug resistance, and infection control in healthcare-associated outbreaks. [PDF]
Du X, Li L.
europepmc +1 more source
Context-dependent immunomodulation by caspofungin: inflammatory attenuation involving spleen tyrosine kinase signaling in monocytic-cell systems versus pathogen-mediated immune amplification. [PDF]
Itoh K, Iwasaki H, Ikawa M, Mitsuke Y.
europepmc +1 more source

